AR
Insider
Allan Reine
Chief Executive OfficerAllan Reine (Chief Executive Officer) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in PRME. Across 1 priced purchase filing, the average 21-session return was +80.0% from execution and +87.8% from disclosure (delay-adjusted; derived). The largest single filing was $148K of PRME (125,000 sh × $1.18, as filed), executed May 21 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+80.0%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+87.8%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$148K
shares × price, as filed
Last traded
May 21 2025
Filed May 22 2025
Volume by month
Buys $148K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
1 filing
Sector per market data · by filing · past 24 months
Most traded names
PRME
PRME
PRME · 1 buy · 0 sells
1 filing
Recent filings
PRMEPURCHASE
Prime Medicine, Inc.
View filing →
$148K125,000 sh × $1.18
Exec May 21 2025
Filed May 22 2025 · 5:30 PM ET